Management of Cancer-Associated Thrombosis: An Evolving Area.
cancer
direct oral anticoagulant
low-molecular weight heparin
risk assessment model
venous thromboembolism
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 Oct 2020
16 Oct 2020
Historique:
received:
09
10
2020
accepted:
14
10
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
22
10
2020
Statut:
epublish
Résumé
The management of cancer-associated thrombosis (CAT) is an evolving area. With the use of direct oral anticoagulants as a new option in the management of CAT, clinicians now face several choices for the individual cancer patient with venous thromboembolism. A personalized approach, matching the right drug to the right patient, based on drug properties, efficacy and safety, side effect profile of each drug, and patient values and preference, will probably supplant the one size fits all approach of use of only low-molecular-weight heparin in the near future. We herein present eight translational, clinical research, and review articles on recent advances in the management of CAT published in the Special Issue "Treatment for Cancer-Associated Thrombosis" of
Identifiants
pubmed: 33081109
pii: cancers12102999
doi: 10.3390/cancers12102999
pmc: PMC7602857
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
J Clin Oncol. 2018 Jul 10;36(20):2017-2023
pubmed: 29746227
Cancers (Basel). 2020 Jul 19;12(7):
pubmed: 32707653
Cancer Med. 2020 Jul 14;:
pubmed: 32663379
Gastroenterology. 2020 Apr;158(5):1346-1358.e4
pubmed: 31843588
N Engl J Med. 2020 Apr 23;382(17):1599-1607
pubmed: 32223112
Cancers (Basel). 2020 Apr 09;12(4):
pubmed: 32283621
Arch Intern Med. 2007 Jul 23;167(14):1471-5
pubmed: 17646600
Lancet Haematol. 2018 Jul;5(7):e289-e298
pubmed: 29885940
Blood. 2013 Sep 5;122(10):1712-23
pubmed: 23908465
Cancers (Basel). 2020 May 26;12(6):
pubmed: 32466430
Cancers (Basel). 2020 Jul 24;12(8):
pubmed: 32722064
Nat Rev Cardiol. 2015 Aug;12(8):464-74
pubmed: 26076949
Blood. 2008 May 15;111(10):4902-7
pubmed: 18216292
Lancet Oncol. 2019 Oct;20(10):e566-e581
pubmed: 31492632
J Thorac Oncol. 2020 Sep;15(9):1497-1506
pubmed: 32437899
J Clin Oncol. 2020 Feb 10;38(5):496-520
pubmed: 31381464
Thromb Haemost. 2017 Oct 5;117(10):1952-1961
pubmed: 28837207
N Engl J Med. 2019 Feb 21;380(8):711-719
pubmed: 30511879
N Engl J Med. 2019 Feb 21;380(8):720-728
pubmed: 30786186
Cancers (Basel). 2019 Dec 14;11(12):
pubmed: 31847343
Haematologica. 2019 Jun;104(6):1277-1287
pubmed: 30606788
Cancers (Basel). 2020 Jun 11;12(6):
pubmed: 32545233
Cancers (Basel). 2020 Jun 28;12(7):
pubmed: 32605234
Cancers (Basel). 2020 May 19;12(5):
pubmed: 32438682
Cancers (Basel). 2020 Aug 13;12(8):
pubmed: 32823554
Cochrane Database Syst Rev. 2016 Dec 01;12:CD008500
pubmed: 27906452
N Engl J Med. 2018 Feb 15;378(7):615-624
pubmed: 29231094
PLoS Med. 2012;9(7):e1001275
pubmed: 22859911
Br J Cancer. 2018 Apr;118(8):1056-1061
pubmed: 29588512
Am J Med. 2006 Jan;119(1):60-8
pubmed: 16431186